Strolll, a pioneering developer of digital therapeutics software for augmented reality glasses, is thrilled to announce a successful funding round in which the company raised $10,350,000. This significant investment marks an incredible milestone for Strolll as it continues its mission to empower movement therapy for individuals living with neurological disorders. The funds will be strategically deployed to accelerate product development, expand market reach, and deepen research into innovative digital health solutions. By harnessing the transformative potential of augmented reality, Strolll’s groundbreaking software provides a tailored and immersive therapy experience that redefines rehabilitation and support for patients, therapists, and caregivers alike.
The fresh infusion of capital will not only fuel technological enhancements but also bolster clinical partnerships and community outreach initiatives. In a healthcare landscape that increasingly values digital and personalized treatment plans, Strolll is well-positioned to address unmet needs and improve quality of life for those impacted by neurological conditions. The company’s commitment to blending advanced AR technology with evidence-based therapeutic practices has already begun to reshape how movement therapy is delivered and experienced, offering new hope and opportunities for recovery. With this funding, the Strolll team plans to expand its research efforts, refine its user interface for enhanced accessibility, and integrate additional therapeutic modalities that cater to a broader range of patient needs. Industry experts and investors alike are excited by the potential of Strolll’s innovative approach to create lasting, meaningful change in digital healthcare and rehabilitation practices.
